Catalyst Wire Dossier Catalyst Wire Dossier

Aclidinium bromide/formoterol fumarate fixed-dose combination

Aclidinium bromide/formoterol fumarate · AstraZeneca
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Aclidinium bromide/formoterol fumarate fixed-dose combination, covering 2016-11-15 to 2019-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]

See pricing